Does Salt Form Matter? A Pilot Randomized, Double-Blind, Crossover Pharmacokinetic Comparison of Crystalline and Regular Glucosamine Sulfate in Healthy Volunteers
Nutrients · 2025
DOI: 10.3390/nu17152491 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Chuck Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research, ISURA, Burnaby, BC V3N 4S9, Canada. Hauptthemen laut MEDLINE: Glucosamine, Sodium Chloride. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ISURA’s research.
Abstract (Originalsprache)
Background
Crystalline glucosamine sulfate (cGS) claims to be a stabilized form of glucosamine sulfate with a defined crystalline structure intended to enhance chemical stability. It is proposed to offer pharmacokinetic advantages over regular glucosamine sulfate (rGS) which is stabilized with potassium or sodium chloride. However, comparative human bioavailability data are limited. Since both forms dissociate in gastric fluid into constituent ions, the impact of cGS formulation on absorption remains uncertain. This pilot study aimed to compare the bioavailability of cGS and rGS using a randomized, double-blind, crossover design.
Methods
Ten healthy adults received a single 1500 mg oral dose of either cGS or rGS with a 7-day washout between interventions. Capillary blood samples were collected over 24 h. Glucosamine and its metabolite concentrations were quantified by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS), and pharmacokinetic parameters—including maximum concentration (Cmax), time to reach Cmax (Tmax), and area under the curve (AUC)—were calculated.
Results
Mean AUC0–24, Cmax, Tmax, and T½ values for glucosamine and glucosamine-6-sulfate (GlcN-6-S) were comparable between cGS and rGS. Although the AUC0–24 for glucosamine was modestly higher with rGS (18,300 ng·h/mL) than with cGS (12,900 ng·h/mL), the difference was not statistically significant (p = 0.136). GlcN-6-S exposure was also similar between formulations (rGS: 50,700 ng·h/mL; cGS: 50,600 ng·h/mL), with a geometric mean ratio of 1.39, a delayed Tmax (6–8 h) and longer half-life, consistent with its role as a downstream metabolite. N-acetylglucosamine levels remained stable, indicating potential homeostatic regulation.
Conclusions
This pilot study found no significant pharmacokinetic advantage of cGS over rGS. These preliminary findings challenge claims of cGS’ pharmacokinetic superiority, although the small sample size limits definitive conclusions. Larger, adequately powered studies are needed to confirm these results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research, ISURA, Burnaby, BC V3N 4S9, Canada.
- Biology Department, University of British Columbia, Kelowna, BC V1V 1V7, Canada.
ORCID-Profile: Chuck Chang, Min Du, Robert O'Brien, Julia Solnier
Förderung
- ISURA’s research
Zitieren
APA
Chang, C., Ibi, A., Zhang, Y., Du, M., Roh, Y. S., O'Brien, R., & Solnier, J. (2025). Does Salt Form Matter? A Pilot Randomized, Double-Blind, Crossover Pharmacokinetic Comparison of Crystalline and Regular Glucosamine Sulfate in Healthy Volunteers. Nutrients. https://doi.org/10.3390/nu17152491
Vancouver
Chang C, Ibi A, Zhang Y, Du M, Roh YS, O'Brien R, et al. Does Salt Form Matter? A Pilot Randomized, Double-Blind, Crossover Pharmacokinetic Comparison of Crystalline and Regular Glucosamine Sulfate in Healthy Volunteers. Nutrients. 2025. doi:10.3390/nu17152491
BibTeX
@article{Chang2025,
author = {Chang, Chuck and Ibi, Afoke and Zhang, Yiming and Du, Min and Roh, Yoon Seok and O'Brien, Robert and Solnier, Julia},
title = {Does Salt Form Matter? A Pilot Randomized, Double-Blind, Crossover Pharmacokinetic Comparison of Crystalline and Regular Glucosamine Sulfate in Healthy Volunteers},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17152491}
}
EUVIMED